Anti-IL-8
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-IL-8, covering 2025-01-17 to 2025-08-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma [Phase 1]